Detalhe da pesquisa
1.
EFFICACY AND SAFETY OF RANIBIZUMAB FOR THE TREATMENT OF CHOROIDAL NEOVASCULARIZATION DUE TO UNCOMMON CAUSE: Twelve-Month Results of the MINERVA Study.
Retina
; 38(8): 1464-1477, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28704254
2.
Competition between ligands for Al2O3 in aqueous solution.
J Phys Chem A
; 116(25): 6511-8, 2012 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-22568392
3.
RANIBIZUMAB 0.5 MG TREATMENT IN ADOLESCENTS WITH CHOROIDAL NEOVASCULARIZATION: SUBGROUP ANALYSIS DATA FROM THE MINERVA STUDY.
Retin Cases Brief Rep
; 15(4): 348-355, 2021 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30395119
4.
Rats can predict aversiveness of Active Pharmaceutical Ingredients.
Eur J Pharm Biopharm
; 133: 77-84, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30267837
5.
Challenges of developing palatable oral paediatric formulations.
Int J Pharm
; 365(1-2): 1-3, 2009 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-18848611
6.
Application of in vitro biopharmaceutical methods in development of immediate release oral dosage forms intended for paediatric patients.
Eur J Pharm Biopharm
; 85(3 Pt B): 833-42, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23665448
7.
Industry perspective on palatability testing in children-two case studies.
Int J Pharm
; 435(2): 139-42, 2012 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-22883699